{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T22:44:03Z","timestamp":1776984243662,"version":"3.51.4"},"reference-count":34,"publisher":"Georg Thieme Verlag KG","issue":"05","funder":[{"name":"Key Research and Development Project of Heilongjiang Province","award":["2022ZX06C12"],"award-info":[{"award-number":["2022ZX06C12"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Planta Med"],"published-print":{"date-parts":[[2026,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The study aims to investigate the pharmacodynamics and pharmacokinetics to elucidate the mechanism of enhanced anticoagulant effect of scutellarin and its preparations on warfarin. Evaluation of pharmacodynamic effects is undertaken by measuring coagulation parameters prothrombin time (PT) and activated partial thromboplastin time (APTT). The UHPLC-ESI-MS\/MS method is used to determine the plasma concentrations of R\/S-warfarin to investigate the influence on the pharmacokinetics. Changes in the plasma protein binding rate of warfarin is studied by ultrafiltration. The results of pharmacodynamics showed that there was no significant difference in PT, international normalized ratio (INR), and APTT between the scutellarin control and the blank control group. Compared to the warfarin control group, scutellarin co-administered with the warfarin group has a significant increase in PT and INR after 8\u2009h, and APTT had no change. The pharmacokinetic results showed that there was an\n          increase in peak concentration (C\n               max) and area under curve (AUC\n               0-t and AUC\n               0\u2013\u221e) and a significant prolongation of half time (t\n               1\/2) and a decrease in apparent clearance (CL\/F) of R-warfarin compared with the warfarin control group. Compared with the warfarin group, the protein binding rates were decreased in all doses of scutellarin co-administered with the warfarin groups, respectively. Scutellarin can enhance the anticoagulant effect of warfarin by both inhibition of the R-warfarin metabolism and reduction in the protein binding rate of warfarin.<\/jats:p>","DOI":"10.1055\/a-2748-8868","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:07:02Z","timestamp":1765238822000},"page":"567-573","source":"Crossref","is-referenced-by-count":0,"title":["Effect of Scutellarin on the Pharmacokinetics and Pharmacodynamics of Warfarin in Rats"],"prefix":"10.1055","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1837-177X","authenticated-orcid":false,"given":"Jiahui","family":"Sun","sequence":"first","affiliation":[{"name":"College of Pharmacy, Harbin Medical University, Harbin, China"},{"name":"Department of Pharmacy, The Second Affiliated Hospital, Harbin Medical University, The Heilongjiang Key Laboratory of Drug Research, Harbin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengnan","family":"Qin","sequence":"first","affiliation":[{"name":"Department of Pharmacy, The Second Affiliated Hospital, Harbin Medical University, The Heilongjiang Key Laboratory of Drug Research, Harbin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Wei","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Harbin Medical University, Harbin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuepeng","family":"Shi","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Harbin Medical University, Harbin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Shao","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Second Affiliated Hospital, Harbin Medical University, The Heilongjiang Key Laboratory of Drug Research, Harbin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaofeng","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, The Second Affiliated Hospital, Harbin Medical University, The Heilongjiang Key Laboratory of Drug Research, Harbin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunjuan","family":"Yang","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Harbin Medical University, Harbin, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2025,12,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1365-2125.1979.tb01009.x","article-title":"Pharmacokinetics and pharmacodynamics of warfarin at steady state","volume":"8","author":"P A Routledge","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/s0731-7085(00)00476-3","article-title":"Development and validation of a sensitive and robust LC-tandem MS method for the analysis of warfarin enantiomers in human plasma","volume":"25","author":"W Naidong","year":"2001","journal-title":"J Pharm Biomed Anal"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/cpt1974162348","article-title":"Studies on the optical enantiomorphs of warfarin in man","volume":"16","author":"R A O\u02bcReilly","year":"1974","journal-title":"Clin Pharmacol Ther"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1097\/FTD.0000000000000594","article-title":"Pharmacokinetic and pharmacodynamic drug monitoring of direct-acting oral anticoagulants: Where do we stand?","volume":"41","author":"E Wieland","year":"2019","journal-title":"Ther Drug Monit"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"751107","DOI":"10.3389\/fphar.2021.751107","article-title":"Interaction between Chinese medicine and warfarin: Clinical and research update","volume":"12","author":"W Zhuang","year":"2021","journal-title":"Front Pharmacol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s40256-020-00401-5","article-title":"Amiodarone: A comprehensive guide for clinicians","volume":"20","author":"D Hamilton Sr.","year":"2020","journal-title":"Am J Cardiovasc Drugs"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3390\/cells10040773","article-title":"The effects of warfarin and direct oral anticoagulants on systemic vascular calcification: A review","volume":"10","author":"K Elango","year":"2021","journal-title":"Cells"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.13748\/j.cnki.issn1007-7693.2020.11.007","article-title":"Simultaneous determination of scutellarin and baicalin in the flowers of Scutellaria Baicalensis Georgi by HPLC","volume":"37","author":"C Hong","year":"2020","journal-title":"Chin J Mod Appl Pharm"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1055\/s-0030-1250353","article-title":"Chromatographic fingerprint and quantitative analysis of seven bioactive compounds of Scutellaria barbata","volume":"77","author":"H Yao","year":"2011","journal-title":"Planta Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s00299-007-0466-9","article-title":"Plant regeneration of Erigeron breviscapus (vant.) Hand. Mazz. and its chromatographic fingerprint analysis for quality control","volume":"27","author":"C Z Liu","year":"2008","journal-title":"Plant Cell Rep"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"e0146197","DOI":"10.1371\/journal.pone.0146197","article-title":"Neuroprotective effect of Scutellarin on ischemic cerebral injury by down-regulating the expression of angiotensin-converting enzyme and AT1 receptor","volume":"11","author":"W Wang","year":"2016","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13020-020-00307-z","article-title":"Anti-colorectal cancer effects of scutellarin revealed by genomic and proteomic analysis","volume":"15","author":"L L Xiong","year":"2020","journal-title":"Chin Med"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"252530","DOI":"10.1155\/2015\/252530","article-title":"Protective effects of scutellarin on type II diabetes mellitus-induced testicular damages related to reactive oxygen species\/Bcl-2\/Bax and reactive oxygen species\/microcirculation\/staving pathway in diabetic rat","volume":"2015","author":"L Long","year":"2015","journal-title":"J Diabetes Res"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1142\/S0192415X21500646","article-title":"Breviscapine: A review on its phytochemistry, pharmacokinetics and therapeutic effects","volume":"49","author":"L Wen","year":"2021","journal-title":"Am J Chin Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"115691","DOI":"10.1016\/j.jep.2022.115691","article-title":"Effects of breviscapine on cerebral ischemia-reperfusion injury and intestinal flora imbalance by regulating the TLR4\/MyD88\/NF-\u03baB signaling pathway in rats","volume":"300","author":"H D Chen","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"458","DOI":"10.13820\/j.cnki.gdyx.20180209.010","article-title":"The safety research on Dengzhanxixin injection","volume":"39","author":"J J Xiang","year":"2018","journal-title":"Guangdong Med J"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"289","DOI":"10.3389\/fphar.2017.00289","article-title":"Therapeutic effects of breviscapine in cardiovascular diseases: A review","volume":"8","author":"J Gao","year":"2017","journal-title":"Front Pharmacol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"113137","DOI":"10.1016\/j.jep.2020.113137","article-title":"Clinical evidence and GRADE assessment for breviscapine injection (DengZhanHuaSu) in patients with acute cerebral infraction","volume":"262","author":"J Lyu","year":"2020","journal-title":"J Ethnopharmacol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"e202200450","DOI":"10.1002\/cbdv.202200450","article-title":"Scutellarin attenuates doxorubicin-induced cardiotoxicity by inhibiting myocardial fibrosis, apoptosis and autophagy in rats","volume":"20","author":"X Sun","year":"2023","journal-title":"Chem Biodivers"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"105599","DOI":"10.1016\/j.phrs.2021.105599","article-title":"Suppression of apoptosis in vascular endothelial cell, the promising way for natural medicines to treat atherosclerosis","volume":"168","author":"H Duan","year":"2021","journal-title":"Pharmacol Res"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"153169","DOI":"10.1016\/j.phymed.2020.153169","article-title":"Scutellarin protects against myocardial ischemia-reperfusion injury by suppressing NLRP3 inflammasome activation","volume":"68","author":"L J Xu","year":"2020","journal-title":"Phytomedicine"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"1538697","DOI":"10.3389\/fphar.2025.1538697","article-title":"Scutellarin ameliorates ischemia\/reperfusion-mediated endothelial dysfunction by upregulating cathepsin D expression to rescue autophagy-lysosomal function","volume":"16","author":"Q Zhuang","year":"2025","journal-title":"Front Pharmacol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"475","DOI":"10.2174\/1570161112666141014150232","article-title":"Effects and perspectives of Chinese patent medicines for tonifying Qi and promoting blood circulation on patients with cerebral infarction","volume":"13","author":"L Zhou","year":"2015","journal-title":"Curr Vasc Pharmacol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.pharmthera.2018.05.006","article-title":"Clinical benefits and pharmacology of scutellarin: A comprehensive review","volume":"190","author":"L Wang","year":"2018","journal-title":"Pharmacol Ther"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"e0129969","DOI":"10.1371\/journal.pone.0129969","article-title":"Breviscapine injection improves the therapeutic effect of western medicine on angina pectoris patients","volume":"10","author":"C Wang","year":"2015","journal-title":"PLoS One"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.4268\/cjcmm20131836","article-title":"Explore dengzhan xixin injection effecting on outcome of coronary heart disease based on propensity score","volume":"38","author":"P F Lu","year":"2013","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.4268\/cjcmm20131843","article-title":"Exploration of clinical outcomes on coronary heart disease of parenterally administered dengzhan xixin using propensity score","volume":"38","author":"H Shen","year":"2013","journal-title":"Chin J Chin Mater Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"640","DOI":"10.2174\/1874467215666220823123852","article-title":"Scutellarin mediates cytochrome P450 3A4 and 2C19 expression via pregnane X receptor and constitutive androstane receptor","volume":"16","author":"H Huang","year":"2023","journal-title":"Curr Mol Pharmacol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1002\/ptr.3723","article-title":"Scutellarin inhibits cytochrome P450 isoenzyme 1A2 (CYP1A2) in rats","volume":"26","author":"T Y Jian","year":"2012","journal-title":"Phytother Res"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1691\/ph.2014.3922","article-title":"In vivo effects of scutellarin on the activities of CYP1A2, CYP2C11, CYP2D1, and CYP3A1\/2 by cocktail probe drugs in rats","volume":"69","author":"Z Lin","year":"2014","journal-title":"Pharmazie"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3969\/j.issn.1001-1978.2011.05.029","article-title":"Determination of plasma protein binding rate of multicomponent in Dengzhanxixin injection","volume":"27","author":"L Zhou","year":"2011","journal-title":"Chin Pharmacol Bull"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/bcpt.13531","article-title":"Effects of Herba Erigerontis injection on pharmacodynamics and pharmacokinetics of warfarin in rats in vivo","volume":"128","author":"M Jiang","year":"2021","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1080\/00498254.2017.1361051","article-title":"Effects of safflower injection on the pharmacodynamics and pharmacokinetics of warfarin in rats","volume":"48","author":"Y Liu","year":"2018","journal-title":"Xenobiotica"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1080\/00498254.2019.1681034","article-title":"Effects of sulfotanshinone sodium injection on the pharmacokinetics and pharmacodynamics of warfarin in rats in vivo","volume":"50","author":"Y Shi","year":"2020","journal-title":"Xenobiotica"}],"container-title":["Planta Medica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2748-8868.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T22:32:50Z","timestamp":1776983570000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2748-8868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,8]]},"references-count":34,"journal-issue":{"issue":"05","published-online":{"date-parts":[[2026,4,23]]},"published-print":{"date-parts":[[2026,4]]}},"URL":"https:\/\/doi.org\/10.1055\/a-2748-8868","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0032-0943","1439-0221"],"issn-type":[{"value":"0032-0943","type":"print"},{"value":"1439-0221","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,8]]}}}